+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine Mastitis Market - Global Forecast 2026-2032- Product Image
Bovine Mastitis Market - Global Forecast 2026-2032- Product Image
Sale

Bovine Mastitis Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084136
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bovine Mastitis Market is projected to reach USD 1.67 Billion in 2026. It is expected to continue growing at a CAGR of 6.04%, reaching USD 2.36 Billion by 2032.

Bovine Mastitis: Executive Overview of a Persistent Dairy-Health Challenge

Bovine mastitis is an inflammatory disease of the mammary gland that reduces animal welfare, milk quality, and farm productivity. It may be caused by contagious or environmental pathogens and can present as clinical disease or subclinical infection. Effective management depends on prevention, early detection, appropriate treatment, hygiene, nutrition, housing, and disciplined milking practices.

Prevention, Detection, and Responsible Treatment Are Reshaping Mastitis Control

Mastitis control is shifting from reaction after visible symptoms to integrated prevention and surveillance. Farms are placing greater emphasis on udder hygiene, milking-equipment maintenance, bedding management, dry-period protocols, somatic-cell monitoring, and pathogen identification. Responsible antimicrobial use is also becoming more important, with treatment decisions increasingly linked to clinical assessment, diagnostic testing, withdrawal requirements, and stewardship principles.

Artificial Intelligence Is Strengthening Early Warning and Farm-Level Decision Support

Artificial intelligence can combine somatic-cell data, milk conductivity, yield changes, milking-system signals, animal activity, and treatment records to identify animals requiring attention. Its practical contribution is strongest when algorithms support trained veterinary and farm personnel rather than replace them. Reliable deployment requires representative data, transparent validation, interoperability with farm systems, privacy safeguards, and ongoing monitoring for false alerts and missed cases.

Regional Conditions Determine How Mastitis Prevention Is Implemented

North America is characterized by structured herd-recording practices, specialized dairy operations, and growing interest in sensor-based monitoring. Latin America faces varied farm scales, climatic conditions, and infrastructure, making practical hygiene programs and accessible diagnostics important. Europe emphasizes animal welfare, traceability, antimicrobial stewardship, and regulatory compliance. The Middle East must address heat stress, water constraints, and intensive production conditions, while Africa often requires adaptable solutions suited to smallholder systems, veterinary-access limitations, and diverse breeds. Asia-Pacific combines highly commercialized dairy sectors with extensive smallholder production, creating demand for scalable training, diagnostics, and context-specific prevention programs.

Economic Blocs and Alliances Shape Standards, Access, and Implementation Capacity

ASEAN markets differ substantially in dairy structure, climate, veterinary access, and cold-chain capability, favoring adaptable regional programs. BRICS members span major dairy-producing, importing, and developing systems, with collaboration opportunities in diagnostics, training, and animal-health infrastructure. The European Union places strong emphasis on food safety, animal welfare, traceability, and prudent antimicrobial use. G7 countries generally have advanced veterinary services, data systems, and quality controls, although farm structures vary. GCC members must account for heat exposure, intensive housing, and reliance on imported inputs. NATO members do not form a single dairy-health system, but their overlapping members can benefit from shared resilience, biosecurity, and research practices.

Country Priorities Reflect Differences in Herd Systems, Climate, and Veterinary Infrastructure

Australia combines pasture-based and intensive dairy systems, requiring regionally tailored monitoring and environmental management. Brazil’s diverse climates and farm structures make hygiene, training, and affordable diagnostics central priorities. Canada and the United States benefit from sophisticated herd-management systems while continuing to focus on prevention, treatment stewardship, and data integration. China and India require approaches that can serve both large commercial farms and smaller producers. Japan and South Korea emphasize quality control, traceability, and technology-enabled herd management. France, Germany, Italy, and Spain are shaped by European welfare, food-safety, and antimicrobial-use expectations. The United Kingdom likewise prioritizes herd health, responsible treatment, and detailed farm assurance. Mexico faces varied production conditions and benefits from scalable veterinary support. Russia’s large geographic range makes logistics, surveillance, and regional adaptability important.

Industry Leaders Should Integrate Prevention, Diagnostics, Stewardship, and Workforce Capability

Leaders should establish measurable mastitis-control protocols covering milking hygiene, housing, bedding, dry-cow management, culling decisions, and staff training. Farms should pair routine somatic-cell and clinical-case records with targeted laboratory testing to distinguish contagious from environmental causes. Digital tools should be introduced through validated pilot programs with clear escalation rules and veterinary oversight. Procurement and operational planning should account for product quality, cold-chain needs, treatment records, withdrawal compliance, and local service capacity. Cross-sector partnerships among producers, veterinarians, laboratories, equipment providers, and regulators can improve standardization and accelerate practical learning.

Methodology: Evidence-Based Synthesis of Disease Management and Industry Conditions

This executive summary uses a structured qualitative synthesis of established veterinary, epidemiological, regulatory, and dairy-management evidence concerning bovine mastitis. The analysis organizes findings across disease biology, prevention, diagnostics, treatment stewardship, digital technologies, regional conditions, economic groupings, and country contexts. Claims are limited to broadly documented relationships and operational considerations; no market estimates, market sizing, market shares, or forecasts are included. Regional and country narratives are interpretive and should be validated against current local surveillance, legislation, production systems, and veterinary guidance before implementation.

Integrated Herd Health Offers the Most Durable Path to Lower Mastitis Burden

Bovine mastitis remains best addressed as a herd-management issue rather than solely an individual-animal treatment problem. Combining prevention, timely detection, accurate diagnosis, responsible therapy, sound nutrition, suitable housing, and skilled personnel can improve animal welfare and milk quality while supporting operational resilience. Artificial intelligence may strengthen these systems, but its value depends on trustworthy data and human judgment. The most effective strategies will be those adapted to local production realities and continuously improved through documented outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bovine Mastitis Market, by Product Type
7.1. Introduction
7.2. Antibiotics
7.2.1. Aminoglycosides
7.2.2. Beta Lactams
7.2.2.1. Cephalosporins
7.2.2.2. Penicillins
7.2.3. Tetracyclines
7.3. Teat Sealants
7.4. Vaccines
8. Bovine Mastitis Market, by Route Of Administration
8.1. Introduction
8.2. Intramammary
8.3. Parenteral
9. Bovine Mastitis Market, by Dosage Form
9.1. Introduction
9.2. Ointment
9.3. Powder
9.4. Solution
10. Bovine Mastitis Market, by Application
10.1. Introduction
10.2. Dry Cow Therapy
10.3. Lactation Therapy
11. Bovine Mastitis Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.4. Online Channels
12. Bovine Mastitis Market, by End User
12.1. Introduction
12.2. Dairy Farms
12.3. Veterinary Clinics
13. Bovine Mastitis Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Bovine Mastitis Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Bovine Mastitis Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Boehringer Ingelheim International GmbH
17.2. Ceva Santé Animale S.A.
17.3. Elanco Animal Health Incorporated
17.4. HIPRA, S.A.
17.5. Huvepharma NV
17.6. IDEXX Laboratories, Inc.
17.7. Merck & Co., Inc.
17.8. Phibro Animal Health Corporation
17.9. Vetoquinol S.A.
17.10. West Way Health
17.11. Zoetis Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Bovine Mastitis Market, Years Considered for the Study
FIGURE 2. Global Bovine Mastitis Market, Research Design
FIGURE 3. Global Bovine Mastitis Market, Research Framework
FIGURE 4. Global Bovine Mastitis Market, Data Triangulation
FIGURE 5. Global Bovine Mastitis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Bovine Mastitis Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Bovine Mastitis Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Bovine Mastitis Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Bovine Mastitis Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Bovine Mastitis Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 11. Global Bovine Mastitis Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Bovine Mastitis Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Bovine Mastitis Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Bovine Mastitis Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Bovine Mastitis Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Bovine Mastitis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Bovine Mastitis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Bovine Mastitis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Bovine Mastitis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Bovine Mastitis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Bovine Mastitis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Bovine Mastitis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Bovine Mastitis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Bovine Mastitis Market Segmentation & Coverage
TABLE 2. Global Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Aminoglycosides Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Aminoglycosides Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Aminoglycosides Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Beta Lactams Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Beta Lactams Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Beta Lactams Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Cephalosporins Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Cephalosporins Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Cephalosporins Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Penicillins Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Penicillins Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Penicillins Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Teat Sealants Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Teat Sealants Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Teat Sealants Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 29. Global Intramammary Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Intramammary Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Intramammary Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 36. Global Ointment Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Ointment Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Ointment Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Dry Cow Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Dry Cow Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Dry Cow Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Lactation Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Lactation Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Lactation Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 53. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Online Channels Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Online Channels Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Online Channels Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 63. Global Dairy Farms Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Dairy Farms Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Dairy Farms Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. North America Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. North America Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 81. North America Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 82. North America Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 83. North America Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 84. North America Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 85. North America Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. North America Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. North America Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Latin America Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Latin America Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 90. Latin America Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 91. Latin America Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 92. Latin America Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 93. Latin America Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 94. Latin America Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Latin America Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. Latin America Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Europe Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Europe Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 99. Europe Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 100. Europe Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 101. Europe Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 102. Europe Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 103. Europe Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Europe Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 105. Europe Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Middle East Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Middle East Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. Middle East Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 109. Middle East Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 110. Middle East Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 111. Middle East Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 112. Middle East Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Middle East Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Middle East Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. Africa Bovine Mastitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Africa Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Africa Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 118. Africa Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 119. Africa Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 120. Africa Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 121. Africa Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Africa Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Africa Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Global Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. ASEAN Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. ASEAN Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 128. ASEAN Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 129. ASEAN Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 130. ASEAN Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 131. ASEAN Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. ASEAN Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. ASEAN Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. GCC Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. GCC Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. GCC Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 137. GCC Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 138. GCC Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 139. GCC Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 140. GCC Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. GCC Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. GCC Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. European Union Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. European Union Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 145. European Union Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 146. European Union Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 147. European Union Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 148. European Union Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. European Union Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. European Union Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. European Union Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. BRICS Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. BRICS Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. BRICS Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 155. BRICS Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 156. BRICS Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 157. BRICS Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 158. BRICS Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 159. BRICS Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 160. BRICS Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. G7 Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. G7 Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. G7 Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 164. G7 Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 165. G7 Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 166. G7 Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 167. G7 Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. G7 Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. G7 Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. NATO Bovine Mastitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. NATO Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 172. NATO Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 173. NATO Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 174. NATO Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 175. NATO Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 176. NATO Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. NATO Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 178. NATO Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Global Bovine Mastitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. United States Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 181. United States Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. United States Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 183. United States Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 184. United States Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 185. United States Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 186. United States Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. United States Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 188. United States Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Canada Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 190. Canada Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Canada Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 192. Canada Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 193. Canada Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 194. Canada Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 195. Canada Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Canada Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. Canada Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. Mexico Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 199. Mexico Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 200. Mexico Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 201. Mexico Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 202. Mexico Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 203. Mexico Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 204. Mexico Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. Mexico Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 206. Mexico Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Brazil Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 208. Brazil Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. Brazil Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 210. Brazil Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 211. Brazil Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 212. Brazil Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 213. Brazil Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Brazil Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 215. Brazil Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. United Kingdom Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 217. United Kingdom Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. United Kingdom Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 219. United Kingdom Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 220. United Kingdom Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 221. United Kingdom Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 222. United Kingdom Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. United Kingdom Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 224. United Kingdom Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 225. Germany Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 226. Germany Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 227. Germany Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 228. Germany Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 229. Germany Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 230. Germany Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 231. Germany Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 232. Germany Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. Germany Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. France Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 235. France Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 236. France Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 237. France Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 238. France Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 239. France Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 240. France Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. France Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. France Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Russia Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 244. Russia Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 245. Russia Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 246. Russia Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 247. Russia Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 248. Russia Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 249. Russia Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. Russia Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 251. Russia Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Italy Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 253. Italy Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Italy Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 255. Italy Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 256. Italy Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 257. Italy Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 258. Italy Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Italy Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Italy Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Spain Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 262. Spain Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. Spain Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 264. Spain Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 265. Spain Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 266. Spain Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 267. Spain Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Spain Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Spain Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. China Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 271. China Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 272. China Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 273. China Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 274. China Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 275. China Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 276. China Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. China Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. China Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. India Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 280. India Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 281. India Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 282. India Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 283. India Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 284. India Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 285. India Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 286. India Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 287. India Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. Japan Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 289. Japan Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 290. Japan Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 291. Japan Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 292. Japan Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 293. Japan Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 294. Japan Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 295. Japan Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 296. Japan Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 297. Australia Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 298. Australia Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Australia Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 300. Australia Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 301. Australia Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 302. Australia Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 303. Australia Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. Australia Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 305. Australia Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. South Korea Bovine Mastitis Market Size, 2017-2032 (USD Million)
TABLE 307. South Korea Bovine Mastitis Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 308. South Korea Bovine Mastitis Market Size, by Antibiotics, 2017-2032 (USD Million)
TABLE 309. South Korea Bovine Mastitis Market Size, by Beta Lactams, 2017-2032 (USD Million)
TABLE 310. South Korea Bovine Mastitis Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 311. South Korea Bovine Mastitis Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 312. South Korea Bovine Mastitis Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. South Korea Bovine Mastitis Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 314. South Korea Bovine Mastitis Market Size, by End User, 2017-2032 (USD Million)
TABLE 315. Global Bovine Mastitis Market Share, by Key Player, 2025
TABLE 316. Global Bovine Mastitis Market, Key Experts

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Elanco Animal Health Incorporated
  • HIPRA, S.A.
  • Huvepharma NV
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • West Way Health
  • Zoetis Inc.

Related Topics

Related Reports

Bovine Mastitis Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease Type, Product, Route of Administration, Therapy - Product Image

Bovine Mastitis Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease Type, Product, Route of Administration, Therapy

  • Report
  • 160 Pages
  • Global
From
Bovine Mastitis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Bovine Mastitis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Bovine Mastitis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Bovine Mastitis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 145 Pages
  • Global
From
Bovine Mastitis Treatment System - Global Strategic Business Report - Product Image

Bovine Mastitis Treatment System - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Elsevier's Review for the NAVLE, 1st Edition - Product Image

Elsevier's Review for the NAVLE, 1st Edition

  • Book

About the Market

Bovine Mastitis Drug is a type of animal pharmaceutical used to treat mastitis, an inflammation of the mammary glands in cows. It is a common and costly disease in dairy herds, and can lead to decreased milk production, increased culling, and increased veterinary costs. Bovine Mastitis Drugs are typically administered intramammary, and can be either systemic or topical. Systemic drugs are absorbed into the bloodstream and distributed throughout the body, while topical drugs are applied directly to the affected area. Common active ingredients in Bovine Mastitis Drugs include antibiotics, anti-inflammatory agents, and antifungals. Some companies in the Bovine Mastitis Drug market include Elanco, Merck Animal Health, Zoetis, Boehringer Ingelheim, and Bayer Animal Health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.